Targeting IRAK4 in Chronic Lymphocytic Leukemia

Starting soon

Conditions studied: Chronic Lymphocytic Leukemia (CLL)

In brief

Patients with chronic lymphocytic leukemia (CLL) followed at Strategic Research Program on CLL will be enrolled and undergo sampling of additional amount of blood at the time of standard blood tests. Leukemic B cells and peripheral blood mononuclear cells (PBMC).

Key facts

Study ID

NCT07741695

Run by

IRCCS San Raffaele

People needed

50

Starts

2026-09-01

Expected to finish

2027-09-01

Last updated by the study team

2026-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 years
• Diagnosis of CLL
• Participant is willing and able to give informed consent for participation in the study.

You may not qualify if…

• Participant is unable or unwilling to provide informed consent for participation in the study

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.